Product ID:A61100, L-ASCORBIC ACID
MSDS Date:12/12/1997
FSC:6810
NIIN:00-993-3500
Status Code:A
MSDS Number: CKNRL

Emergency Phone: 201-796-7100;800-424-9300(CHEMTREC)

Info Phone: 201-796-7100

Cage: 1B464

Telephone: 201-796-7100

Cage: 1B464

ASCORBIC ACID

CAS: 50-81-7

RTECS: CI7650000

OSHA PEL NOT EXTABLISHED

LD50 LC50 Mixture:ORAL LD50 (RAT) IS 11900MG/KG
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:TARGET ORGANS: NONE. EYES: MAY CAUSE
MILD TRANSIENT IRRITATION. SKIN: LOW HAZARD FOR USUAL INDUSTRIAL
HANDLING. INGEST: LOW HAZARD FOR USUAL INDUSTRIAL HANDLING MAY
CAUSE MILD DIGESTIVE TRACT IRRITATI ON. INHALATION: MAY CAUSE
RESPIRATORY TRACT IRRITATION. CHRONIC: NO INFORMATION FOUND.
Explanation of Carcinogenicity:50-81-7 NOT LISTED BY ACGIH, IARC,
NIOSH, NTP OR OSHA.
Effects of Overexposure:IRRITATION, MILD DIGESTIVE TRACT IRRITATION,
RESPIRATORY TRACT IRRITATION.

First Aid:EYES: IMMEDIATELY FLUSH EYES WITH PLENTY OF WATER FOR AT
LEAST 15 MINUTES, OCCASSIONALLY LIFTING THE UPPER AND LOWER LIDS.
GET MEDICAL AID. SKIN: IMMEDIATELY FLUSH SKIN WITH PLENTY OF SOAP
AND WATER F OR AT LEAST 15 MINUTES WHILE REMOVING CONTAMINATED
CLOTHING AND SHOES. GET MEDICAL AID IF IRRITATION DEVELOPS OR
PERSISTS. INGESTION: IF VICTIM IS CONSCIOUS AND ALERT, GIVE 2-4
CUPFULS OF MILK OR WATE R. GET MEDICAL AID. INHALATION: REMOVE FROM
EXPOSURE TO FRESH AIR IMMEDIATELY. IF NOT BREATHING, GIVE
ARTIFICIAL RESPIRATION. IF BREATHING IS DIFFICULT, GIVE OXYGEN. GET
MEDICAL AID IF COUGH OR OTHER SYMPTOMS APPEAR.

Flash Point:NONE
Autoignition Temp:=660.C, 1220.F
Extinguishing Media:FOR SMALL FIRES, WATER SPRAY, DRY CHEMICAL, CARBON
DIOXIDE, ALCOHOL-RESISTANT FOAM.
Fire Fighting Procedures:AS IN ANY FIRE, WEAR A SELF-CONTAINED
BREATHING APPARATUS IN PRESSURE-DEMAND, MSHA/NIOSH (APPROVED OR
EQUIVALENT) AND FULL PROTECTIVE GEAR. USE WATER SPRAY TO KEEP
FIRE-EXPOSED CONTAINERS COOL.

Spill Release Procedures:CAREFULLY SCOOP UP AND PLACE INTO APPROPRIATE
DISPOSAL CONTAINER.

Handling and Storage Precautions:STORE IN A COOL, SRY, WELL-VENTILATED
AREA AWAY FROM INCOMPATIBLE SUBSTANCES. WASH THOROUGHLY AFTER
HANDLING. REMOVE CONTAMINATED CLOTHING & WASH BEFORE REUSE. USE
WITH ADEQUATE VENTILATION. MINIMIZE DUST GENERATION &
ACCUMULATION. AVOID CONTACT WITH SKIN & EYES. AVOID INGESTION &
INHALATION.
Other Precautions:NOTES TO PHYSICIAN: TREAT SYMPTOMATICALLY AND
SUPPORTIVELY. ANTIDOTES: NO SPECIFIC ANTIDOTE EXISTS. GENERAL
INFORMATION: USE PROPER PROTECTIVE EQUIPMENY AN INDICATED IN
CONTROL SECTION.

Respiratory Protection:FOLLOW THE OSHA RESPIRATOR REGULATIONS FOUND IN
29 CFR 1910.134 OR EUROPEAN STANDARD EN 149. ALWAYS USE A NIOSH OR
EUROPEAN EN 149 RESPIRATOR WHEN NECESSARY.
Ventilation:USE ADEQUATE VENTILATION TO KEEP AIRBORNE CONCENTRATIONS
LOW.
Protective Gloves:APPROPRIATE PROTECTIVE GLOVES.
Eye Protection:PROTECTIVE EYEGLASSES OR CHEMICAL SAFETY GOGGLES.
Other Protective Equipment:WEAR APPROPRIATE PROTECTIVE CLOTHING TO
PREVENT SKIN EXPOSURE. WEAR APPROPIATE PROTECTIVE EYEGLASSES OR
CHEMICAL SAFETY GOGGLES AS DESCRIBED BY OSHA'S EYE & FACE
PROTECTION REGULATIONS IN 29 CFR 1910.13
Work Hygienic Practices:WASH THOROUGHLY AFTER HANDLING. REMOVE
CONTAMINATED CLOTHING & WASH BEFORE RESUE. USE WITH ADEQUATE
VENTILATION. MINIMIZE DUST GENERATION AND ACCUMULATION.
Supplemental Safety and Health

HCC:N1
Melt/Freeze Pt:=190.C, 374.F
Decomp Temp:=190.C, 374.F
Vapor Pres:NEGLIGIBLE
Spec Gravity:1.65
pH:3 @.5%
Solubility in Water:APPRECIABLE;33%
Appearance and Odor:SOLID, WHITE TO YELLOW; NO REPORTED ODOR

Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZERS.
Stability Condition to Avoid:INCOMPATIBLE MATERIALS, IGNITION SOURCES,
EXCESS HEAT.
Hazardous Decomposition Products:CARBON MONOXIDE, CARBON DIOXIDE

Waste Disposal Methods:DISPOSE OF IN A MANNER CONSISTENT WITH
FEDERAL,STATE AND LOCAL REGULATIONS.

Toxicological Information:RTECS#: CAS#: 50-81-7: CI7650000. LD50/LC50:
CAS# 50-81-7: ORAL, MOUSE: LD50=3367 MG/KG; ORAL, RAT: LD50=11900
MG/KG. TETRATOGENICITY: EFFECTS ON NEWBORN: BIOCHEMICAL &
METABOLIC, ORAL-GUINEA PIG TDLO =19500 MG/KG; GROWTH STATICS,
ORAL-GUINES PIG TDLO=2471 MG/KG; STILLBIRTH, ORAL-GUINES PIG
TDLO=5800 MG/KG. SPECIFIC DEVELOPMENTAL ABNORMALITIES: CENTRAL
NERVOUS SYSTEM AND MUSCOLOSKELETAL, INTERVENOU S-MOUSE TDLO=800
MG/KG. REPRODUCTIVE EFFECTS: FERTILITY: POST-IMPLANTATION
MORTALITY, ORAL-RAT TDLO=25000 MG/KG.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecological:NO INFORMATION AVAILABLE.

Transport Information:NO INFORMATION AVAILABLE.

SARA Title III Information:SECTION 302 (RQ): NO. SECTION 302(TPQ): NO.
SECTION 3131: NO.
Federal Regulatory Information:TSCA: CAS#50-81-7 IS LISTED ON THE TSCA
INVENTORY. OSHA: NO.
State Regulatory Information:CAS# 50-81-7 IS NOT PRESENT ON STATE LISTS
FROM CA, PA, MN, MA, FL OR NJ. CALIFORNIA NI SIGNIFICANT RISK
LEVEL: NONE OF THE CHEMICALS IN THIS PRODUCT ARE LISTED.